Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)

Back

ESC Premium Access

Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)

Session: Pulmonary hypertension: progress in management, impact on outcomes

Topic: Pharmacotherapy

Speaker: Associate Professor A. Marra (Naples, IT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Associate Professor Alberto Maria Marra

University of Naples Federico II, Naples (Italy)

0 follower

9 more presentations in this session

Fast screening breath analysis for diagnostics of pulmonary hypertension.

Speaker: Assistant Professor A. Swinarew (Katowice, PL)

Phenomapping to detect non-invasively patients with combined postcapillary pulmonary hypertension

Speaker: Doctor O. Raitiere (Le Havre Cedex, FR)

Impact of comorbidity on outcome in CTD-associated pulmonary arterial hypertension: data from the Swedish Pulmonary Arterial Hypertension Registry

Speaker: Doctor C. Hjalmarsson (Gothenburg, SE)

Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

Speaker: Professor N. Galie (Bologna, IT)

Improved ten-year survival of systemic sclerosis-associated pulmonary arterial hypertension in the contemporary treatment era: a single centre retrospective study of 451 patients.

Speaker: Doctor H. Fayed (London, GB)

Access the full session

Pulmonary hypertension: progress in management, impact on outcomes

Speakers: Associate Professor A. Marra, Assistant Professor A. Swinarew, Doctor O. Raitiere, Doctor C. Hjalmarsson, Professor N. Galie...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources